Research and InnovationResearch Radar
Genetic implications of schizophrenia for cardiovascular disease
Study reveals a genetic link between schizophrenia and risk factors for cardiovascular disease. As a group, people with...
By João L. de Quevedo, MD, PhD
Published on · Last reviewed on · 2 min read
A study reveals a genetic link between schizophrenia and risk factors for cardiovascular disease.
As a group, people with schizophrenia appear to be genetically predisposed to start smoking and to smoke more cigarettes per day, according to a genomic analysis
which examined the relationship between schizophrenia and several risk factors for cardiovascular disease. The findings were published in The American Journal of Psychiatry.
“Schizophrenia is associated with a two- to threefold higher risk of cardiovascular disease compared with the risk in the general population, contributing to a reduction in life expectancy of 10 to 20 years,” wrote Linn Rødevand, Ph.D., of the Norwegian Centre for Mental Disorders Research at the University of Oslo, and colleagues. Although some of this risk is believed to result from lifestyle factors (for example, smoking) and limited access to health care, research also suggests that the genetic makeup of some individuals with schizophrenia may increase their risk of cardiovascular disease.
To understand the genetic overlap between schizophrenia and risk factors for cardiovascular disease, Rødevand and colleagues analyzed data from genome-wide association studies (GWAS). GWAS is a research approach used to identify genomic variants that are associated—positively or negatively—with the risk of a disease or with a particular trait.
The results for schizophrenia were obtained from the Psychiatric Genomics Consortium, comprising 53,386 patients with schizophrenia and 77,258 control participants of European ancestry. The GWAS data on risk factors for cardiovascular disease included millions of people and examined factors such as smoking initiation, the number of cigarettes smoked per day, body mass index (BMI), type 2 diabetes, blood pressure, and many more.
In addition to the risk of smoking and the number of cigarettes smoked per day, genetic overlap was found between schizophrenia and other risk factors, such as BMI. However, people with schizophrenia were found to be genetically predisposed to a lower BMI, on average—despite obesity being more common in individuals with schizophrenia than in those in the general population. This strongly suggests the influence of environmental factors, including the effects of antipsychotic medications and socioeconomic challenges that contribute to unhealthy lifestyles, on the prevalence of obesity among patients with schizophrenia.
“Studies with larger GWAS will reveal more about the genetic architecture of schizophrenia and may reveal differences in genetic liability for [cardiovascular disease] in subsets of patients,” the researchers wrote. “These findings may provide clinically useful insights that pave the way for risk stratification and more personalized interventions.”
Related content
Research and Innovation
From Brexanolone to Psychedelics: The New Frontier of Psychiatric Pharmacotherapy
After decades of modest advances in psychopharmacology, psychiatry is finally entering a new era — marked not by incremental adjustments...
· Article
Mood Disorders
Celebrating 75 Years Since the Discovery of Lithium
Discovered by Swedish chemist Johan August Arfwedson in 1817, lithium's potential truly began to unfold on May 5,...
· Article
Mood Disorders
Understanding the complexity of catatonia
Catatonia, a perplexing neuropsychiatric condition, often remains poorly understood despite its profound impact on...
· Explainer